ICTR in the News: Six Johns Hopkins Doctors Elected to Association of American Physicians
Posted by: Crystal Williams on: April 24, 2017 | Print This Page
The following article profiles the Association of American Physicians inductions of ICTR researchers Stephen B. Baylin, M.D., Peter Calabresi, M.D., Garry R. Cutting, M.D., Sherita Hill Golden, M.D., Frank Giardiello, M.D., and Justin McArthur, M.B.B.S., M.P.H.
Six Johns Hopkins physicians were elected to the Association of American Physicians at the annual meeting of the organization April 21-23 in Chicago.
The Association of American Physicians is a nonprofit, professional organization whose goals include the pursuit of medical knowledge, and the advancement through experimentation and discovery of basic and clinical science and their application to clinical medicine. Each year, individuals who have attained excellence in achieving these goals are nominated for membership by the Council of the Association. Their election gives them the opportunity to share their scientific discoveries and contributions with their colleagues at the annual meeting.
Johns Hopkins electees to the association:
Stephen B. Baylin, M.D., is the Virginia and D.K. Ludwig Professor of Oncology and Medicine, co-director of the Cancer Biology Division and associate director for Research Programs of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. His research interests include cellular biology and genetics of cancer, specifically epigenetics or genetic modifications other than those in DNA that can affect cell behavior, and silencing of tumor suppressor genes and tumor progression. His research has looked at the mechanisms through which variations in tumor cells derive, and cell differentiation in cancers such as medullary thyroid carcinoma and small cell lung carcinoma.
Peter Calabresi, M.D., is the director of the Multiple Sclerosis (MS) Center and a professor of neurology at Johns Hopkins. He focuses on the diagnosis and management of MS. He oversees several clinical trials and research projects seeking to create new anti-inflammatory and neuroprotective therapies for MS. Calabresi is also working on a new way of using magnetic resonance imaging (MRI) in a study that assesses damage to nerve fibers and myelin in the brain and spinal cord. Calabresi is a member of the National Multiple Sclerosis Society’s Clinical Trials Committee, a member of the American Neurological Association, and a member of the board of trustees, Maryland chapter, National Multiple Sclerosis Society.
Garry R. Cutting, M.D., is the Aetna/U.S. Healthcare Professor of Pediatrics and Medicine, McKusick-Nathans Institute of Genetic Medicine. Cutting’s research is focused on the causes of phenotype variation in the single gene disorder Cystic Fibrosis (CF). He directs a worldwide project called CFTR2 that aims to characterize the clinical and functional consequences of all variants reported in the CF transmembrane conductance regulator (CFTR), the gene that causes CF. Cutting’s laboratory is a leader in the quantification of genetic and non-genetic factors to trait variation in CF and the elucidation of interactions among these factors. Cutting directs the DNA Diagnostic Laboratory at Johns Hopkins and the Translational Technology Core of the Institute for Clinical Translational Research at Hopkins. He is a member of the American Society of Clinical Investigation and the Society for Pediatric Research, and the editor of the genetics journal Human Mutation.
Sherita Hill Golden, M.D., is the Hugh P. McCormick Family Professor of Endocrinology and Metabolism and executive vice chair of the Department of Medicine at the Johns Hopkins University School of Medicine. She holds joint appointments in the Welch Center for Prevention, Epidemiology and Clinical Research, in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, and in the Armstrong Institute for Patient Safety and Quality. She is director of the Johns Hopkins Hospital Inpatient Glucose Management Program. Golden’s primary research interests center on identifying endocrine risk factors associated with the development of diabetes and cardiovascular disease; examining mental health complications of diabetes and the biological, hormonal, and behavioral factors that explain these associations; understanding and eliminating diabetes health disparities; and implementing and evaluating systems interventions to improve patient safety and quality of care in hospitalized patients with diabetes. She was chairperson of the Endocrine Society’s first Scientific Statement on Health Disparities in Endocrine Disorders. She also serves as the principal investigator of the Johns Hopkins site of the Diabetes Prevention Program Outcome Study. In 2013, she was elected to the American Society for Clinical Investigation.
Frank Giardiello, M.D., is the Johns G. Rangos Sr. Professor of Medicine, the program director for the gastrointestinal fellowship and director of the Johns Hopkins Colorectal Cancer Registry and Risk Assessment Clinic. He served for nine years as the director of the Division of Gastroenterology at The Johns Hopkins University. Giardiello’s clinical and research interests have focused on the study of cancer and cancer chemoprevention in the gastrointestinal tract. This has included the investigation of the genetic basis of familial colorectal cancer and the use of genetic testing in the hereditary forms of colorectal cancer. He also has an interest in the study of the genotypic phenotypic correlations in the polyposis syndromes, which include familial adenomatous polyposis, juvenile polyposis and Peutz-Jeghers syndrome.
Justin McArthur, M.B.B.S., M.P.H., is the director of the Department of Neurology and holds the John W. Griffin Professorship in Neurology at Johns Hopkins. He is internationally recognized for his work in studying the development and treatment of HIV, multiple sclerosis, and other neurological infections and neurological disorders originating from the immune system. McArthur developed a technique using nerves under the skin to study neuropathies, including those associated with chemotherapy, HIV and diabetes. He is also the director of the Johns Hopkins/National Institute of Mental Health Research Center for Novel Therapeutics of HIV-associated Cognitive Disorders. The center studies the nature of HIV-associated cognitive disorders with the aim of finding new therapeutics for HIV-associated dementia.
FOR THE MEDIA